Horizon Pharma plc to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference

DUBLIN, Ireland, May 30, 2018 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP), today announced that the company will participate in the Goldman Sachs 39th Annual Global Healthcare Conference on Tuesday, June 12, 2018 and will present at 10:40 a.m. PT.

The presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com.  A replay of the webcast will be available for the event.

About Horizon Pharma plc
Horizon Pharma plc is focused on researching, developing and commercializing innovative medicines that address unmet treatment needs for rare and rheumatic diseases.  By fostering a growing pipeline of medicines in development and exploring all potential uses for currently marketed medicines, we strive to make a powerful difference for patients, their caregivers and physicians.  For us, it’s personal:  by living up to our own potential, we are helping others live up to theirs.  For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter, like us on Facebook or explore career opportunities on LinkedIn.

Investors:                                                                     U.S. Media:
Tina Ventura                                                                  Geoff Curtis
Senior Vice President,                                                   Senior Vice President,
Investor Relations                                                          Corporate Affairs & Chief Communications Officer
investor-relations@horizonpharma.com                        media@horizonpharma.com

Ruth Venning                                                                  Ireland Media:
Executive Director,                                                          Ray Gordon
Investor Relations                                                           Gordon MRM   
investor-relations@horizonpharma.com                         ray@gordonmrm.ie